natgillin/translations-raw huggingface dataset:
Melanoma and non-melanoma skin cancer (NMSC) have been reported in patients treated with TNF- antagonists, including etanercept.
Pri bolnikih, zdravljenih z antagonisti TNF, vključno z etanerceptom, so poročali o melanomu in nemelanomskem kožnem raku (NMSC- Non-Melanoma Skin Cancer).
Melanoma combination (with ipilimumab): studies CA209038, CA209067 and CA209069
Melanom, kombinirano zdravljenje (z ipilimumabom): študije CA209038, CA209067 in CA209069
Melanoma has been reported in patients treated with TNF-blocking agents, including Simponi.
Pri bolnikih, ki so se zdravili z zaviralci TNF, vključno z zdravilom Simponi, so poročali o melanomu.
Melanoma monotherapy: studies CA209038 and CA209066
Melanom, monoterapija: študiji CA209038 in CA209066
melanoma or suspicious skin lesion
melanom ali sumljiva lezija na koži;
melanoma**
maligni melanom
melanoma**
Neželeni učinki
melanoma, a skin cancer, which has spread to other parts of the body or cannot be surgically removed; non-small cell lung cancer (NSCLC), which has spread nearby or to other parts of the body in patients who have previously been treated with at least one chemotherapy regimen.
z napredovalim melanomom, vrsto kožnega raka, ki se je razširil na druge dele telesa ali ga ni mogoče kirurško odstraniti; z nedrobnoceličnim pljučnim rakom (NSCLC), ki se je razširil v okolico ali v druge dele telesa pri bolnikih, ki so se predhodno zdravili z vsaj eno predhodno kemoterapijo.
Melatonin does not induce CYP1A enzymes in vitro at supra-therapeutic concentrations.
Melatonin ne inducira CYP1A encimov in vitro pri koncentracijah, višjih kot so terapevtske.
Melatonin has been observed to induce CYP3A in vitro at supra-therapeutic concentrations.
Opazili so, da melatonin inducira CYP3A in vitro pri koncentracijah, višjih kot so terapevtske.
Melatonin is involved in co-ordinating the body’s sleep cycle by acting on cells in specific areas of the brain and helping to bring about sleep.
Melatonin sodeluje pri usklajevanju cikla spanja v telesu tako, da učinkuje na celice v določenih predelih možganov in spodbuja spanje.
Melatonin’s metabolism is mainly mediated by CYP1A enzymes.
Melatonin v glavnem presnavljajo CYP1A encimi.
MELD scoref
Ocena po MELDf
Melosus 1.5 mg/ml oral suspension for dogs Meloxicam
Melosus 1,5 mg/ml, peroralna suspenzija za pse Meloksikam
Melosus contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).
Zdravilo Melosus vsebuje meloksikam, ki spada v skupino zdravil, imenovanih nesteroidna protivnetna zdravila (NSAID).
Melosus contains the active substance meloxicam in a strength of 0.5 mg/ml (cats) or 1.5 mg/ml (dogs) for the oral suspension.
Zdravilo Melosus vsebuje zdravilno učinkovino meloksikam v jakosti 0,5 mg/ml (mačke) ali 1,5 mg/ml (psi) v peroralni suspenziji.
Melosus is a ‘generic’ which means that Melosus is similar to a ‘reference veterinary medicine’ already authorised in the EU (Metacam).
Zdravilo Melosus je generično zdravilo, kar pomeni, da je podobno referenčnemu veterinarskemu zdravilu, ki je že odobreno v EU (zdravilu Metacam).
Melosus is presented as a pale yellow oral suspension which is to be given mixed with food or directly into the mouth in dogs or cats.
Zdravilo Melosus je na voljo v obliki bledo rumene peroralne suspenzije, ki se psom ali mačkam daje pomešana s hrano ali neposredno v gobec.
Melosus is used in dogs to relieve inflammation and pain in musculo-skeletal disorders.
Zdravilo Melosus se pri psih uporablja za lajšanje vnetja in bolečine pri kostno-mišičnih obolenjih.
Melovem 20 mg/ml solution for injection for cattle, pigs and horses
Melovem 20 mg/ml raztopina za injiciranje za govedo, prašiče in konje
Melovem 20 mg/ml solution for injection for cattle, pigs and horses Meloxicam
Melovem 20 mg/ml raztopina za injiciranje za govedo, prašiče in konje Meloksikam
Melovem 30 mg/ml solution for injection for cattle and pigs
Melovem 30 mg/ml raztopina za injiciranje za govedo in prašiče
Melovem 30 mg/ml solution for injection for cattle and pigs Meloxicam
Melovem 30 mg/ml raztopina za injiciranje za govedo in prašiče Meloksikam
Melovem 5 mg/ml solution for injection for cattle and pigs
Melovem 5 mg/ml, raztopina za injiciranje za govedo in prašiče
Melovem 5 mg/ml solution for injection for cattle and pigs Meloxicam
Melovem 5 mg/ml, raztopina za injiciranje za govedo in prašiče Meloksikam
Melovem contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).
Zdravilo Melovem vsebuje meloksikam, ki spada v skupino zdravil, imenovanih nesteroidna protivnetna zdravila (NSAID).
Melovem is a ‘generic’.
Zdravilo Melovem je „generično zdravilo“.
Meloxicam 0.5 mg (equivalent to 0.017 mg per drop)
Meloksikam 0,5 mg (kar ustreza 0,017 mg v 1 kapljici)
Meloxicam 0.5 mg (equivalent to 0.017 mg per drop).
Meloksikam 0,5 mg (kar ustreza 0,017 mg v 1 kapljici).
Meloxicam 0.5 mg (equivalent to 0.02 mg per drop)
Meloksikam 0,5 mg (kar ustreza 0,02 mg v 1 kapljici)
Meloxicam 0.5 mg Sodium benzoate 1.5 mg
Natrijev benzoat 1,5 mg
Meloxicam 1 mg
Zdravilna učinkovina Meloksikam 1 mg
Meloxicam 1.5 mg
Zdravilna učinkovina Meloksikam 1,5 mg
Meloxicam 1.5 mg (equivalent to 0.05 mg per drop)
Meloksikam 1,5 mg (kar ustreza 0,05 mg v 1 kapljici)
Meloxicam 1.5 mg (equivalent to 0.05 mg per drop).
Meloksikam 1,5 mg (kar ustreza 0,05 mg v 1 kapljici).
Meloxicam 15 mg
Zdravilna učinkovina Meloksikam 15 mg
Meloxicam 15 mg/ml Sodium benzoate 5 mg/ml
Meloksikama: 15 mg/ml Natrijevega benzoata: 5 mg/ml
Meloxicam 2.5 mg.
Meloksikam 2,5 mg.
Meloxicam 20 mg/ml
Meloksikam 20 mg
Meloxicam 40 mg/ml
meloksikam 40 mg/ml
Meloxicam 5 mg
Zdravilna učinkovina Meloksikam 5 mg
Meloxicam 5 mg,
Meloksikam 5 mg
Meloxicam 5 mg/ml
meloksikam 5 mg/ml etanol 96-odstotni 159.8 mg/ml
Meloxicam 5 mg/ml Excipients: Ethanol 150 mg/ml
Meloksikam 5 mg/ml
Meloxicam 5 mg/ml.
Meloksikam: 5 mg/ml
Meloxicam 5 mg/ml.
meloksikam: 5 mg/ml etanol 96-odstotni: 159.8 mg/ml
Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by E. coli endotoxin administration in calves and pigs.
Deluje tudi antiendotoksično, saj so dokazali, da zavira nastajanje tromboksana B2, izzvano z vnosom endotoksina E. coli pri teletih, kravah v obdobju laktacije in prašičih.
Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by E. coli endotoxin administration in calves, lactating cows and pigs.
Deluje tudi antiendotoksično, saj so dokazali, da zavira nastajanje tromboksana B , izzvano z vnosom endotoksina E. coli pri teletih, kravah v obdobju
Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by E. coli endotoxin administration in calves, lactating cows and pigs.
Deluje tudi antiendotoksično, saj so dokazali, da zavira nastajanje tromboksana B , izzvano z vnosom endotoksina E. coli pri teletih, kravah v obdobju laktacije in prašičih.
Meloxicam in Novem 20 mg/ml solution for injection for cattle and pigs is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Meloksikam v zdravilu Novem 20 mg/ml, raztopina za injiciranje za goveda in prašiče, je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.
Meloxicam in Novem 5 mg/ml solution for injection for cattle and pigs is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Meloksikam v zdravilu Novem 5 mg/ml, raztopina za injiciranje za goveda in prašiče, je dovoljena učinkovina, kot je navedena v tabeli 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Meloksikam je nesteroidna protivnetna učinkovina (NSAID) iz skupine oksikamov, ki zavira sintezo prostaglandinov in tako deluje protivnetno, analgetično, antieksudativno in antipiretično.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Meloksikam je nesteroidno protivnetno zdravilo (NSAID) iz skupine oksikamov, ki zavira tvorbo prostaglandinov in tako deluje protivnetno, analgetično, antieksudativno in antipiretično.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic, anti-exudative and antipyretic effects.
Meloksikam je nesteroidno protivnetno zdravilo (NSAR) iz skupine oksikamov, ki zavira tvorbo prostaglandinov in tako deluje protivnetno, analgetično, antieksudativno in antipiretično.
Meloxicam is eliminated with a half-life of 26 hours and 17.5 hours after subcutaneous injection in young cattle and lactating cows, respectively.
Razpolovna doba izločanja meloksikama je po podkožni injekciji pri mladem govedu in kravah v obdobju laktacije 26 oziroma 17,5 ure.
Meloxicam is eliminated with a terminal half-life of 7.7 hours.
Končna razpolovna doba izločanja meloksikama je 7,7 ure.
Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Meloksikam se pretežno nahaja v plazmi in je tudi pomemben produkt pri izločanju z žolčem, medtem ko so v urinu samo sledi matične spojine.
Meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Meloksikam se pretežno nahaja v plazmi in je tudi pomembna sestavina pri izločanju zdravila z žolčem, medtem ko vsebuje urin samo sledi matične spojine.
Meloxicam is predominantly found in plasma.
Meloksikam se nahaja pretežno v plazmi.
Meloxicam may be harmful for the foetus and unborn child.
Meloksikam je lahko škodljiv za plod ali nerojenega otroka.
Meloxidolor 20 mg/ml solution for injection for cattle, pigs and horses
Meloxidolor 20 mg/ml, raztopina za injiciranje za govedo, prašiče in konje
Meloxidolor 20 mg/ml solution for injection for cattle, pigs and horses Meloxicam
Meloxidolor 20 mg/ml, raztopina za injiciranje za govedo, prašiče in konje Meloksikam
Meloxidolor 5 mg/ml solution for injection for dogs, cats, cattle and pigs
Meloxidolor 5 mg/ml, raztopina za injiciranje za pse, mačke, govedo in prašiče
Meloxidolor 5 mg/ml solution for injection for dogs, cats, cattle and pigs Meloxicam
Meloksidolor 5 mg/ml, raztopina za injiciranje za pse, mačke, govedo in prašiče Meloksikam
Meloxidolor 5 mg/ml solution for injection for dogs, cats, cattle and pigs Meloxicam
Meloxidolor 5 mg/ml, raztopina za injiciranje za pse, mačke, govedo in prašiče Meloksikam
Meloxidolor contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).
Zdravilo Meloxidolor vsebuje meloksikam, ki spada v skupino nesteroidnih protivnetnih zdravil (NSAID).
Meloxidolor is a ’generic’.
Meloxidolor je generično zdravilo.
Meloxidyl 0.5 mg/ml oral suspension for cats
Meloxidyl 0.5 mg/ml, peroralna suspenzija za mačke.
Meloxidyl 0.5 mg/ml oral suspension for cats 15 & 5 ml
Meloxidyl 0.5 mg/ml peroralna suspenzija za mačke 15 ml & 5 ml
Meloxidyl 1.5 mg/ml - Meloxidyl 5 mg/ml - Meloxidyl 0.5 mg/ml
Meloxidyl 1.5 mg/ml - Meloxidyl 5 mg/ml – Meloxidyl 0.5 mg/ml
Meloxidyl 1.5 mg/ml oral suspension for dogs.
Meloxidyl 1.5 mg/ml peroralna suspenzija za pse.
Meloxidyl 1.5 mg/ml oral suspension for dogs.
Meloxidyl 1.5 mg/ml, peroralna suspenzija za pse.
Meloxidyl 20 mg/ml solution for injection for cattle, pigs and horses
Meloxidyl 20 mg/ml, raztopina za injiciranje za goveda,prašiče in konje
Meloxidyl 20 mg/ml solution for injection for cattle, pigs, horses 50, 100, & 250 ml
Meloxidyl 20 mg/ml, raztopina za injiciranje za goveda,prašiče in konje 50, 100 & 250 ml
Meloxidyl 20 mg/ml solution for injection for cattle, pigs, horses Meloxicam
Meloxidyl 20 mg/ml, raztopina za injiciranje za goveda,prašiče in konje Meloxicam
Meloxidyl 20 mg/ml solution for injection for cattle, pigs, horses Meloxicam
Meloxidyl 20 mg/ml, raztopina za injiciranje za goveda,prašiče, konje Meloxicam
Meloxidyl 20 mg/ml solution for injection for cattle, pigs, horses Meloxicam
Meloxidyl 20 mg/ml, raztopina za injiciranje za goveda,prašiče, konje.
Meloxidyl 5 mg/ml solution for injection for dogs and cats
Meloxidyl 5 mg/ml raztopina za injiciranje za pse in mačke
Meloxidyl 5 mg/ml solution for injection for dogs, cats 10 ml
Meloxidyl 5 mg/ml raztopina za injiciranje za pse in mačke 10 ml
Meloxidyl 5 mg/ml solution for injection for dogs, cats Meloxicam
Meloxidyl 5 mg/ml raztopina za injiciranje za pse in mačke Meloksikam
Meloxidyl is a ‘generic’: this means that Meloxidyl is similar to a ‘reference veterinary medicinal product’ already authorised in the EU (Metacam).
Zdravilo Meloxidyl je „generično“ zdravilo, kar pomeni, da je podobno „referenčnemu veterinarskemu zdravilu“, ki je že odobreno v EU (zdravilu Metacam).
Meloxidyl® must not be administered in conjunction with other NSAIDs or glucocortisosteroids.
Meloxidyl ne smemo dajati hkrati z drugimi nesteroidnimi protivnetnimi zdravili ali glukokortikosteroidi..
Meloxivet 0.5 mg/ml oral suspension for dogs
Meloxivet 0,5 mg/ml, peroralna suspenzija za pse
Meloxivet 1.5 mg/ml oral suspension for dogs
Meloxivet 1,5 mg/ml, peroralna suspenzija za pse
Meloxivet contains meloxicam, which belongs to a class of medicines called nonsteroidal anti- inflammatory drugs (NSAIDs).
Zdravilo Meloxivet vsebuje meloksikam, ki spada v skupino zdravil, ki jim pravimo nesteroidna protivnetna zdravila (NSAID).
Meloxivet must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Zdravila Meloxivet ne smemo dajati skupaj z drugimi nesteroidnimi protivnetnimi zdravili ali glukokortikosteroidi.
Meloxoral 0.5 mg/ml oral suspension for cats
Meloxoral 0,5 mg/ml, peroralna suspenzija za mačke
Meloxoral 1.5 mg/ml oral suspension for dogs
Meloxoral 1,5 mg/ml peroralna suspenzija za pse
Meloxoral 1.5 mg/ml oral suspension for dogs Meloxicam
Meloxoral 1,5 mg/ml peroralna suspenzija za pse Meloksikam
Meloxoral contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).
Zdravilo Meloxoral vsebuje meloksikam, ki spada v skupino zdravil, imenovanih nesteroidna protivnetna zdravila (NSAID).
Meloxoral is a ‘generic’ which means that Meloxoral is similar to a ‘reference veterinary medicine’ already authorised in the EU (Metacam).
Zdravilo Meloxoral je generično zdravilo, kar pomeni, da je podobno referenčnemu veterinarskemu zdravilu, ki je že odobreno v EU (zdravilu Metacam).
Melphalan
melfalan
Melphalan (9 mg/m2) and prednisone (60 mg/m2) are both given orally on days 1, 2, 3 and 4 of the first week of each cycle.
Melfalan (9 mg/m2) in prednizon 60 mg/m2) se dajeta peroralno na 1., 2., 3 in 4 dan prvega tedna vsakega kroga zdravljenja.
Melphalan and prednisone should both be given orally on days 1, 2, 3 and 4 of the first week of each Bortezomib Hospira treatment cycle.
Melfalan in prednizon je treba dati peroralno na 1., 2., 3. in 4. dan v prvem tednu vsakega kroga zdravljenja z zdravilom Bortezomib Hospira.
Melphalan dose should be calculated according to the litre-volume method of Wieberdink (Wieberdink J, Benckhuysen C, Braat RP, van Slooten EA, Olthius GAA.
Odmerek melfalana je treba izračunati po Wieberdinkovi litrsko-volumski metodi (Wieberdink J, Benckhuysen C, Braat RP, van Slooten EA, Olthius GAA.
Melphalan is given during the same operation over 60 minutes, beginning 30 minutes after the start of the Beromun perfusion, when the temperature should be increased to 39 to 40°C. The dose of melphalan depends on the size of the arm or leg.
Med istim postopkom, 30 minut po začetku perfuzije z zdravilom Beromun, se doda melfalan v trajanju 60 minut, pri čemer je treba temperaturo povečati na 39 do 40 °C. Odmerek melfalana je odvisen od velikosti roke ali noge.
Melphalanc,d,e
melfalanc,d,e
Memantine Accord 10 mg film-coated tablets
Memantin Accord 10 mg
Memantine Accord 10 mg film-coated tablets Memantine hydrochloride
Memantin Accord 10 mg filmsko obložene tablete memantinijev klorid
Memantine Accord 10mg film-coated tablets are presented as white, oblong, coated and scored tablet, debossed with “MT” divided by the score on one side and “10” divided by the score on the other side.
Memantin Accord 10 mg filmsko obložene tablete so bele, ovalne, obložene tablete z razdelilno zarezo in vtisnjeno oznako "MT" na eni strani zareze in vtisnjeno številko "10" na drugi strani zareze.
Memantine Accord 10mg film-coated tablets Memantine hydrochloride
Memantin Accord 10 mg filmsko obložene tablete memantinijev klorid
Memantine Accord 15mg film-coated tablets are presented as orange to grey-orange, oblong, coated tablet, debossed with “MT” on one side and “15” on the other side.
Memantin Accord 15 mg filmsko obložene tablete so oranžne do sivo oranžne, ovalne obložene tablete z vtisnjeno oznako "MT" na eni strani in vtisnjeno številko "15" na drugi strani.
Memantine Accord 20 mg film-coated tablets
Memantin Accord 20 mg
Memantine Accord 20 mg film-coated tablets Memantine hydrochloride
Memantin Accord 20 mg filmsko obložene tablete memantinijev klorid
Memantine Accord 20mg film-coated tablets are presented as pale red to greyred, oblong, coated and scored tablet, debossed with “MT” divided by the score on one side and “20” divided by the score on the other side.
Memantin Accord 20 mg filmsko obložene tablete so bledo rdeče do sivo rdeče, ovalne obložene tablete z razdelilno zarezo z vtisnjeno oznako "MT" na eni strani zareze in vtisnjeno številko "20" na drugi strani zareze.
Memantine Accord 5 mg film-coated tablets Memantine Accord 10 mg film-coated tablets Memantine Accord 15 mg film-coated tablets Memantine Accord 20 mg film-coated tablets Memantine hydrochloride
Memantin Accord 5 mg filmsko obložene tablete Memantin Accord 10 mg filmsko obložene tablete Memantin Accord 15 mg filmsko obložene tablete Memantin Accord 20 mg filmsko obložene tablete memantinijev klorid
Memantine Accord 5 mg film-coated tablets Memantine Accord 10mg film-coated tablets Memantine Accord 15mg film-coated tablets Memantine Accord 20mg film-coated tablets Memantine hydrochloride
Memantin Accord 5 mg filmsko obložene tablete Memantin Accord 10 mg filmsko obložene tablete Memantin Accord 15 mg filmsko obložene tablete Memantin Accord 20 mg filmsko obložene tablete memantinijev klorid
Memantine Accord 5mg film-coated tablets are presented as white, oblong, coated tablet, debossed with “MT” on one side and “5” on the other side.
Memantin Accord 5 mg filmsko obložene tablete so bele, ovalne obložene tablete z vtisnjeno oznako "MT" na eni strani in vtisnjeno številko "5" na drugi strani.
Memantine Accord acts on these NMDA-receptors improving the transmission of nerve signals and the memory.
Memantin Accord deluje na receptorje NMDA in izboljša prenos živčnih signalov in spomin.
Memantine Accord belongs to a group of medicines called NMDA-receptor antagonists.
Memantin Accord spada v skupino zdravil, ki se imenujejo antagonisti receptorjev NMDA.
Memantine Accord is a ‘generic medicine’.
Zdravilo Memantine Accord je „generično zdravilo“.
Memantine Accord is not recommended for children and adolescents under the age of 18years.
Zdravila Memantin Accord ne priporočajo otrokom in mladostnikom, mlajšim od 18 let.
Memantine Accord should be administered once a day and should be taken at the same time every day.
Zdravilo Memantin Accord je treba dajati enkrat dnevno in ob istem času vsak dan.
Memantine Accord with food and drink
Jemanje zdravila Memantin Accord skupaj s hrano in pijačo
Memantine Accordbelongs to a group of medicines known as anti-dementia medicines.
Memantin Accord sodi v skupino zdravil, znanih kot zdravila za zdravljenje demence.
Memantine Accordfilm-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28 tablets, 30tablets, 42 tablets, 50tablets, 56tablets, 98 tablets, 100tablets and 112tablets.
Memantin Accord filmsko obložene tablete se nahajajo v pretisnih omotih (PVC/PE/PVDC-aluminijev pretisni omot) v škatlah z 14 tabletami, 28 tabletami, 30 tabletami, 42 tabletami, 50 tabletami, 56 tabletami, 98 tabletami, 100 tabletami in 112 tabletami.
Memantine Accordfilm-coated tablets are available in blister packs (PVC/PE/PVDC-aluminium blister) of 14 tablets, 28tablets, 42tablets, 56tablets and 98tablets.
Memantin Accord filmsko obložene tablete se nahajajo v pretisnih omotih (PVC/PE/PVDC-aluminijev pretisni omot) v škatlah z 14 tabletami, 28 tabletami, 42 tabletami, 56 tabletami in 98 tabletami.
Memantine Accordis used for the treatment of patients with moderate to severe Alzheimer’s disease.
Zdravilo Memantin Accord uporabljamo za zdravljenje bolnikov z zmerno do hudo Alzheimerjevo boleznijo.
Memantine did not inhibit CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A, flavin containing monooxygenase, epoxide hydrolase or sulphationin vitro.
Memantin in vitro ni zaviral CYP 1A2, 2A6, 2C9, 2D6, 2E1, 3A, monooksigenaze, ki vsebuje flavin, epoksidne hidroksilaze ali sulfatacije.
Memantine has an absolute bioavailability of approximately 100 %. tmax is between 3 and 8hours.
Memantin ima absolutno biološko uporabnost okoli 100 %. tmax je med 3 in 8 urami.
Memantine hydrochloride Week 1, Day 1 2 3 4 5 6 7
Teden 1, Dan 1 2 3 4 5 6 7
Memantine is a voltage-dependent, moderate-affinity uncompetitive NMDA-receptor antagonist.
Memantin je napetostno odvisni, nekompetitivni antagonist receptorjev NMDA, z zmerno afiniteto.
Memantine is eliminated in a monoexponential manner with a terminal t½ of 60 to 100 hours.
Memantin se izloča na monoeksponentni način s terminalnim razpolovnim časom (t1/2) od 60 do 100 ur.
Memantine LEK 10 mg
Memantin LEK 10 mg
Memantine LEK 10 mg film-coated tablets are available in PVC/PVDC–Aluminium blister packs of 28, 30, 42, 50, 56, 60, 98, 100 and 112 tablets.
Memantin LEK 10 mg filmsko obložene tablete so na voljo v pretisnih omotih iz PVC / PVDC- aluminija s 28, 30, 42, 50, 56, 60, 98, 100 in 112 tablet.
Memantine LEK 10 mg film-coated tablets are presented as yellow, oval film-coated tablet scored in one side.
Memantin LEK 10 mg filmsko obložene tablete so predstavljene kot rumene, ovalne, filmsko obložene tablete z razdelilno zarezo na eni strani.
Memantine LEK 10 mg film-coated tablets Memantine hydrochloride
Memantin LEK 10 mg filmsko obložene tablete memantinijev klorid
Memantine LEK 10 mg film-coated tablets Memantine LEK 20 mg film-coated tablets Memantine hydrochloride
Memantin LEK 10 mg filmsko obložene tablete Memantin LEK 20 mg filmsko obložene tablete memantinijev klorid
Memantine LEK 10 mg film-coated tablets.
Memantin LEK 10 mg filmsko obložene tablete
Memantine LEK 20 mg
Memantin LEK 20 mg
Memantine LEK 20 mg film-coated tablets are available in PVC/PVDC–Aluminium blister packs of 28, 30, 42, 56, 98 and 100 tablets.
Memantin LEK 20 mg filmsko obložene tablete so na voljo v pretisnih omotih iz PVC / PVDC- aluminija s 28, 30, 42, 56, 98 in 100 tablet.
Memantine LEK 20 mg film-coated tablets Memantine hydrochloride
Memantin LEK 20 mg filmsko obložene tablete memantinijev klorid
Memantine LEK 20 mg film-coated tablets.
Memantin LEK 20 mg filmsko obložene tablete
Memantine LEK acts on these NMDA-receptors improving the transmission of nerve signals and the memory.
Zdravilo Memantin LEK deluje na receptorje NMDA in izboljša prenos živčnih signalov in spomin.
Memantine LEK belongs to a group of medicines called NMDA receptor antagonists.
Zdravilo Memantin LEK spada v skupino zdravil, ki se imenujejo antagonisti receptorjev NMDA.
Memantine LEK is a medicine used to treat patients with moderate to severe Alzheimer’s disease, a type of dementia (a brain disorder) that gradually affects memory, intellectual ability and behaviour.
Memantine LEK je zdravilo, ki se uporablja za zdravljenje bolnikov z zmerno do hudo Alzheimerjevo boleznijo, vrsto demence (možganske bolezni), ki postopoma prizadene spomin, intelektualno sposobnost in vedenje.